Stacey (Hanekamp) Moreno

Title: The Innovative Contributions of Stacey (Hanekamp) Moreno

Introduction

Stacey (Hanekamp) Moreno is a notable inventor based in Spring Valley, CA (US). He has made significant contributions to the field of ocular health through his innovative research and patented methods. With a total of 2 patents, Moreno's work focuses on treating retinal degenerative diseases.

Latest Patents

Moreno's latest patents include groundbreaking methods for preserving cone cells in the eye of mammals suffering from retinal degenerative diseases. One patent describes a method that involves isolating lineage negative hematopoietic stem cells from the bone marrow, transfecting them with a gene that encodes an antiangiogenic fragment of human tryptophanyl tRNA synthetase (TrpRS), and intravitreally injecting these cells into the eye. This method aims to inhibit the degeneration of cone cells in the retina. Additionally, his other patent focuses on isolated, adult bone marrow-derived lineage negative hematopoietic stem cell populations that contain endothelial progenitor cells capable of rescuing retinal blood vessels and neuronal networks in the eye. These innovations are crucial for the treatment of ocular vascular diseases.

Career Highlights

Moreno is affiliated with the Scripps Research Institute, where he continues to advance his research in ocular health. His work has garnered attention for its potential to improve treatments for patients suffering from various retinal conditions.

Collaborations

Some of Moreno's notable coworkers include Martin Friedlander and Karen Da Silva, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Stacey (Hanekamp) Moreno's innovative work in the field of ocular health demonstrates his commitment to advancing medical treatments for retinal diseases. His patents reflect a significant step forward in the preservation of vision and the treatment of ocular conditions.